AsliBademli 
CE mark is required for each medical device sold in EU. Since 26th May 2021 all new devices put on the market shall comply with the applicable requirements of EU medical device regulation. Although the transitional period can be used for current MDD certificates for Class III, Class IIb and Class IIa until 2024 and …
MDR Technical documentation requirements will be one of the main challenges for the medical device manufacturers during transition from 93/42/EEC (MDD) to EU 2017/745 (MDR). As explained on “How to CE Mark your medical device” article, preparation of the technical file is a critical milestone. Since there is no grandfathering for the devices on the …
The change journey of the EU medical device directives since 2012 was completed on 5 May 2017 with the publication of EU 2017/745 and EU/2017/746 in the EU official journal. EU 2017/746, which we are accustomed to briefly refer to as IVDR, entered into force on 26 May 2022. However, due to the COVID 19 …
EU Commission has announced EU MDR 2017/745 designation of 40th notified body (NB). The number of Notified Bodies is expected to increase with the issue of the amendment for MDR extension on 20 March 2023 .With increasing number of NBs manufacturers may find more options to certify their devices. Since beginning of 2019, when the …
Many medical device’s manufacturers have difficulties in locating a notified body for CE Marking of their products. This article provides detailed information on the notified body selection criteria which could be implemented by manufacturers who are planning to put their medical devices on the EU market. Still with 40 NBs for MDR and 10 NBs …
We all know that Risk Management is an important part of a medical device’s quality management system. It also plays an important role in establishing objective evidence for the conformity with the General Safety and Performance Requirements (GSPR) of the EU 2017/746 (IVDR) IVD Medical Device Regulation. When carrying out a risk assessment, the state-of-the-art …
Performance evaluation (PE) is an important part of design validation and technical documentation required to place an in vitro diagnostic device (IVD) on the EU market. Article 56 of the EU 2017/746 In Vitro Diagnostics Regulation (IVDR) requires manufacturers to prepare a performance evaluation report to demonstrate the safety and performance according to the manufacturer’s …
European Commission published the official text of the proposal to extend the MDR transition period for legacy devices on 6 January 2023. The amendment has been formally adopted by both the European Parliament and the Council on 15 March 2023.On 20 March 2023,it has been published in the Official Journal and entered into force. As …
MDCG 2023-3-The guidance document on vigilance terms and concepts as outlined in the Regulation (EU) 2017/745 on medical devices has been published by MDCG. The purpose of this guidance is to clarify important terms and concepts that are outlined in Section 2 of Chapter VII of the Regulation (EU) 2017/745 on medical devices (MDR). This …
The guidance document MDCG 2020-21– Guidance on Periodic Safety Update Report (PSUR) according to Regulation (EU) 2017/745 which is highly anticipated has been published on 16 December 2022 by MDCG. The guidance document, which provides information about the content, format and frequency of preparation for the PSUR, which must be prepared during and after the …